14-day RSI
48.41
+2.24+4.85%
24 December 2024
Summary:
Lipocine stock 14-day relative strength index is 48.41, with the most recent change of +2.24 (+4.85%) on 24 December 2024. According to this value, LPCN stock is neither oversold nor overboughtLPCN RSI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
LPCN RSI Performance
| PeriodPeriod | 14-day RSI14-day RSI | PricePrice | 50-day SMA50-day SMA | 200-day SMA200-day SMA |
|---|---|---|---|---|
| todaytoday | +4.8% | -2.3% | -0.1% | +0.1% |
| 1 m1 month | +25.6% | +8.3% | +1.0% | +1.9% |
| 3 m3 months | -12.1% | +4.3% | +15.3% | +10.0% |
| 6 m6 months | -6.5% | -36.3% | -19.1% | +29.8% |
| ytdytd | -9.0% | +74.0% | +98.1% | +36.9% |
| 1 y1 year | -20.9% | +62.8% | +98.8% | +35.3% |
| 5 y5 years | +125.0% | -22.9% | -76.7% | -83.6% |
LPCN RSI High & Low
| PeriodPeriod | HighHigh | Current vs highvs high | LowLow | Current vs lowvs low | |
|---|---|---|---|---|---|
| 1 m | 1 month | 56.51 | -14.3% | 37.71 | +28.4% |
| 3 m | 3 months | 71.16 | -32.0% | 37.71 | +28.4% |
| 6 m | 6 months | 71.16 | -32.0% | 25.74 | +88.1% |
| 1 y | 1 year | 89.84 | -46.1% | 25.74 | +88.1% |
| 3 y | 3 years | 89.84 | -46.1% | 18.93 | +155.7% |
| 5 y | 5 years | 89.84 | -46.1% | 18.84 | +156.9% |
| alltime | all time | 89.84 | -46.1% | 0.00 | -100.0% |
Lipocine Stock RSI History
| Date | Value |
|---|---|
| 2024 | 48.41(-9.0%) |
| 2023 | 53.21(+21.7%) |
| 2022 | 43.73(+8.8%) |
| 2021 | 40.18(-11.3%) |
| 2020 | 45.32(+69.0%) |
| 2019 | 26.82(-45.2%) |
| Date | Value |
|---|---|
| 2018 | 48.90(+12.5%) |
| 2017 | 43.45(-11.8%) |
| 2016 | 49.26(-7.1%) |
| 2015 | 53.04(-0.5%) |
| 2014 | 53.33(+12.8%) |
| 2013 | 47.26 |
FAQ
- What is Lipocine 14-day relative strength index?
- What is the all time high 14-day RSI for Lipocine?
What is Lipocine 14-day relative strength index?
The current 14-day RSI of LPCN is 48.41
What is the all time high 14-day RSI for Lipocine?
Lipocine all-time high 14-day relative strength index is 89.84